Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in GSK — GSK plc

CIK 1596800 VANCOUVER, A1

Position in GSK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$145,077,119
-$10,417,670 QoQ
Shares Held
2,767,591
-1.8% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#20
of 1,033 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names. GSK ranks #3 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 GSK
GSK plc
This page
2,767,591 $145,077,119

All Filings in GSK

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $145,077,119 2,767,591
2026-03-31 $155,494,789 2,817,445
2025-12-31 $85,188,266 1,737,118
2025-09-30 $20,733,373 480,384
2025-06-30 $3,747,609 97,594
2025-03-31 $8,931,933 230,561
2024-12-31 $7,013,388 207,374
2024-09-30 $23,094,501 564,934
2024-06-30 $4,181,677 108,615
2022-09-30 $24,895,543 845,924
2022-06-30 $48,329,776 1,131,998
2020-06-30 $32,332,401 808,172
2020-03-31 $22,934,844 617,150